SALT LAKE CITY, UT / ACCESS Newswire / October 23, 2025 / Utah Medical Products, Inc. (UTMD) reports third quarter (3Q) and first nine months (9M) of calendar year 2025 financial results that were ...
SALT LAKE CITY, Jan. 30, 2020 (GLOBE NEWSWIRE) -- In the final calendar quarter (4Q) of 2019, Utah Medical Products, Inc. (Nasdaq: UTMD) began to realize accretive profits net of the quarterly ...
The 2Q percentage decline in consolidated revenues was less than for 1H primarily because the period-to-period decline in UTMD sales to its previously major biopharmaceutical OEM customer PendoTECH ...
Although the UK IIA amortization expense in GBP was the same as in the prior year's same periods, the 3Q 2025 OI margin was diluted by 0.3 percentage points, and the 9M 2025 OI margin was diluted by 0 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results